Showing results (1481-1490 of 1,515) with videos related to

Sort By:
Pageof 152
Open Forum Infectious Diseases|July 28, 2025
Systematic Review and Expert Consensus on the Use of Long-acting Monoclonal Antibodies for Prevention of Respiratory Syncytial Virus Disease: ARMADA (Advancing RSV Management And Disease Awareness) TaskforcePaolo Manzoni, Eugenio Baraldi, Fabio Midulla, et al.
Experimental Dermatology|February 1, 2022
Unusual dermoscopic patterns of basal cell carcinoma mimicking melanomaEleonora Di Matteo, Riccardo Pampena, Maria A Pizzichetta, et al.
Critical Reviews in Oncology/Hematology|September 11, 2018
Early mortality in myeloma patients treated with first-generation novel agents thalidomide, lenalidomide, bortezomib at diagnosis: A pooled analysisSara Bringhen, Massimo Offidani, Salvatore Palmieri, et al.
The European Respiratory Journal|September 28, 2019
European Respiratory Society guideline on long-term management of children with bronchopulmonary dysplasiaLiesbeth Duijts, Evelien R van Meel, Laura Moschino, et al.
The Journal of Infectious Diseases|August 15, 2020
Presumed Risk Factors and Biomarkers for Severe Respiratory Syncytial Virus Disease and Related Sequelae: Protocol for an Observational Multicenter, Case-Control Study From the Respiratory Syncytial Virus Consortium in Europe (RESCEU)Kimberley Jefferies, Simon B Drysdale, Hannah Robinson, et al.
Pediatric Pulmonology|July 17, 2025
A Simplified, Regional Lung Ultrasound Score for Surfactant Administration in Neonatal RDS: A Prospective Observational StudyFrancesco Raimondi, Pasquale Dolce, Claudio Veropalumbo, et al.
International Journal of Environmental Research and Public Health|September 9, 2022
Excellent Response to OnabotulinumtoxinA: Different Definitions, Different PredictorsRaffaele Ornello, Carlo Baraldi, Fayyaz Ahmed, et al.
Pain and Therapy|March 29, 2021
Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter StudyRaffaele Ornello, Fayyaz Ahmed, Andrea Negro, et al.
Blood|April 14, 2012
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myelomaMichele Cavo, Lucia Pantani, Maria Teresa Petrucci, et al.
Pain and Therapy|September 26, 2021
Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 PatientsRaffaele Ornello, Fayyaz Ahmed, Andrea Negro, et al.
Pageof 152